All Posts Tagged With: "ASCO"

What Hedge-Fund Managers are Reading This Morning

Last May, shares of Regeneron Pharmaceuticals (REGN), a billion-dollar biotech, slid 35% in just 30 days. The company had no press releases, no earnings reports, nothing.

Receive These Valuable Investing Strategy Resources to Your Inbox Courtesy of Contrarian Profits

    Subscribe
We respect your privacy.
Choose any of the FREE subscription services below that you'd like to receive, enter your email address, and click 'subscribe'.
Contrarian Profits

The Daily Reckoning



Select Edition:
Penny Sleuth

Money Morning

Investor's Daily Edge

Money Morning UK

Investment U

Whiskey and Gunpowder

Taipan Daily

Offshore A-Letter

Today's Financial News

International Living

The Smart Profits Report

Spiritual Wealth